ALHCNasdaqHospital & Medical Service PlansFiscal year ends December 31
Alignment Healthcare, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$8.40+0.12 (+1.45%)
Close on Oct 19, 2026
- Market cap
- $1.81B
- P/E (TTM)
- 49.4
- Dividend yield
- –
Share price
−$8.72 (−50.93%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Alignment Healthcare, Inc. grew revenue 37.2% to $4.58B over the twelve months to Jun 30, 2026. Free cash flow was $177.51M, up 524.9% from a year earlier.
Revenue
$4.58B
+37.2% vs. a year earlier
Operating income
$55.00M
TTM Q2 2026
Free cash flow
$177.51M
+524.9% vs. a year earlier
EPS, diluted
$0.17
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.81B
- P/E ratio
- 49.4
- Price to sales
- 0.39
- Price to book
- 6.81
- Dividend yield
- –
- Free cash flow yield
- 9.83%
Fundamentals
- Revenue
- $4.58B
- Net income
- $40.70M
- EPS, diluted
- $0.17
- Free cash flow
- $177.51M
- Book value per share
- $1.23
- Diluted shares
- 215M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$4.58B+37.2% YoY
Operating income
$55.00M
Net income
$40.70M
EPS, diluted
$0.17
Free cash flow
$177.51M+524.9% YoY
Reported periodTrailing twelve months